Quality-Of-Life Changes In Women With Female Androgenetic Alopecia Treated With A Methylsulfonylmethane-Containing 5-Alpha-Reductase Inhibitor: A Clinical Practice Study
September 2026
in “
Actas Dermo-Sifiliográficas
”
Not medical advice or a treatment recommendation. Read the original study, and consult a qualified healthcare professional before changing treatment. Full disclaimer